Artículos por temáticas

Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.

Peralta C, Biafore F, Depetris TS, Bastianello M.

Curr Neurol Neurosci Rep. 2019 Jun 29;19(8):56. doi: 10.1007/s11910-019-0966-3. Review.

Movement Disorders Journal: Yesterday, Today, Tomorrow, and Always.

Obeso JA, Stoessl AJ, Nash JL, Olanow CW.

Mov Disord. 2019 Dec;34(12):1814-1816. doi: 10.1002/mds.27944. No abstract available.

Antisense therapies for movement disorders.

Scoles DR, Pulst SM.

Mov Disord. 2019 Aug;34(8):1112-1119. doi: 10.1002/mds.27782. Epub 2019 Jul 8. Review.

The Impact of Microelectrode Recording on Lead Location in Deep Brain Stimulation for the Treatment of Movement Disorders.

Kochanski RB, Bus S, Brahimaj B, Borghei A, Kraimer KL, Keppetipola KM, Beehler B, Pal G, Metman LV, Sani S.

World Neurosurg. 2019 Aug 23. pii: S1878-8750(19)32248-X. doi: 10.1016/j.wneu.2019.08.092. [Epub ahead of print]

Movement disorders and nonmotor neuropsychological symptoms in children and adults with classical galactosemia.

Kuiper A, Grünewald S, Murphy E, Coenen MA, Eggink H, Zutt R, Rubio-Gozalbo ME, Bosch AM, Williams M, Derks TGJ, Lachmann RHL, Brouwers MCGJ, Janssen MCH, Tijssen MA, de Koning TJ.

J Inherit Metab Dis. 2019 May;42(3):451-458. doi: 10.1002/jimd.12054. Epub 2019 Feb 27.

The use of transcranial magnetic stimulation as a treatment for movement disorders: A critical review.

Latorre A, Rocchi L, Berardelli A, Bhatia KP, Rothwell JC.

Mov Disord. 2019 Apr 29. doi: 10.1002/mds.27705. [Epub ahead of print] Review.

Cognitive approach to rehabilitation in children with hyperkinetic movement disorders post-DBS.

Gimeno H, Brown RG, Lin JP, Cornelius V, Polatajko HJ.

Neurology. 2019 Feb 22. pii: 10.1212/WNL.0000000000007092. doi: 10.1212/WNL.0000000000007092. [Epub ahead of print]

Abstracts of the 2019 International Congress of the Parkinson's Disease and Movement Disorders®.

[No authors listed]

Mov Disord. 2019 Oct;34 Suppl 2:S1-S930. doi: 10.1002/mds.27795. No abstract available.

The interindividual variability of transcranial magnetic stimulation effects: Implications for diagnostic use in movement disorders.

Latorre A, Rocchi L, Berardelli A, Bhatia KP, Rothwell JC.

Mov Disord. 2019 Jul;34(7):936-949. doi: 10.1002/mds.27736. Epub 2019 Jun 10. Review.

The Legacy of Charles David Marsden: A Role Model in the Field of Movement Disorders.

Zubko LEBM, Franco MKP, Meira AT, Germiniani FMB, Camargo CHF, Teive HAG.

Eur Neurol. 2019 Sep 19:1-4. doi: 10.1159/000502736. [Epub ahead of print] Review.

Movement Disorders and Voice.

Snow G, Guardiani E.

Otolaryngol Clin North Am. 2019 May 7. pii: S0030-6665(19)30059-3. doi: 10.1016/j.otc.2019.03.018. [Epub ahead of print] Review.

How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.

Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van E

Mov Disord. 2019 Mar 18. doi: 10.1002/mds.27666. [Epub ahead of print]

Movement disorders in 2018: tackling this evil at the roots.

Vidailhet M.

Lancet Neurol. 2019 Jan;18(1):8-10. doi: 10.1016/S1474-4422(18)30464-2. No abstract available.

Localising movement disorders in childhood.

Bamford NS, McVicar K.

Lancet Child Adolesc Health. 2019 Oct 22. pii: S2352-4642(19)30330-X. doi: 10.1016/S2352-4642(19)30330-X. [Epub ahead of print] Review.

Movement Disorders in Children.

Pearson TS, Pons R.

Continuum (Minneap Minn). 2019 Aug;25(4):1099-1120. doi: 10.1212/CON.0000000000000756.